SOPHiA GENETICS at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
SOPHiA GENETICS brings 2 presentations to AMP 2026 in Seattle, and exhibits at Booth 715. Its sessions centre on running tissue and liquid biopsy through one workflow, with real-world results and multicentric validation of a pan-cancer liquid biopsy assay. The company supplies an artificial intelligence platform that healthcare institutions use to analyze genomic and radiomic data.
| Organization | AMP 2026 Attendance |
|---|---|
SOPHiA GENETICS Saint-Sulpice, Switzerland | |
SOPHiA AI platform for analyzing genomic and radiomic data, used by healthcare institutions for clinical research. | Booth Exhibiting at Booth 715 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am One Integrated Workflow from Tissue to Liquid Biopsy: Real-World Insights on MSK-IMPACT® Flex and MSK-ACCESS® powered with SOPHiA DDM™ One platform covering tissue and blood comprehensive genomic profiling, with real-world results from a cancer centre. Workshop Wed, Nov 11 9:00am–9:50am Scaling Decentralized Pan-Cancer Liquid Biospy: Multicentric Validation of MSK-ACCESS® powered with SOPHiA DDM™ Multi-site validation of a pan-cancer blood test, covering variants, copy number, fusions, MSI and circulating tumour DNA. |
Instantly find 20 buyers from SOPHiA GENETICS
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction